Chemotherapy rechallenge in metastatic colon cancer: A case report and literature review

Keyphrases

• Metastatic Colorectal Cancer (mCRC) 100%
• Oxaliplatin 100%
• Chemotherapy Rechallenge 100%
• Disease Progression 60%
• Irinotecan 60%
• Colorectal Cancer 40%
• Metastatic Disease 40%
• Heavily Treated 40%
• Rechallenge 40%
• FOLFOX 40%
• United States 20%
• Tumor 20%
• Medical History 20%
• 5-fluorouracil (5-FU) 20%
• Computed Tomography 20%
• Metastasis 20%
• Older Men 20%
• Presentation Time 20%
• Atrial Fibrillation 20%
• Cancer Tumor 20%
• Clinical Conditions 20%
• Microsatellite Instability-high (MSI-H) 20%
• Survival Benefit 20%
• Colectomy 20%
• Chemotherapy Regimen 20%
• Paucity 20%
• Therapeutic Strategies 20%
• Chemoresistant 20%
• Cancer Causes 20%
• Cancer Mortality 20%
• Bevacizumab 20%
• Cetuximab 20%
• Anastomosis 20%
• Systemic Chemotherapy 20%
• Mass Lesion 20%
• Mutational Analysis 20%
• Systemic Therapy 20%
• Carcinoembryonic Antigen Levels 20%
• Hepatic Lesion 20%
• Prolonged Life 20%
• Third-line Therapy 20%
• Well-differentiated Adenocarcinoma 20%
• Abdominal Tenderness 20%
• Leucovorin 20%
• Intraoperative Pathology 20%
• Metastatic Burden 20%
• Pembrolizumab 20%
• BRAF Wild Type 20%
• Later-line Treatment 20%
• Splenic Flexure 20%

Medicine and Dentistry

• Oxaliplatin 100%
• Metastatic Colon Cancer 100%
• Metastatic Carcinoma 60%
• Disease Exacerbation 60%
• Irinotecan 60%
• Colorectal Carcinoma 40%
• Metastatic Colorectal Cancer 40%
• FOLFOX 40%
• Diseases 20%
• Malignant Neoplasm 20%
• Neoplasm 20%
• Medical History 20%
• Fluorouracil 20%
• Computer Assisted Tomography 20%
• Atrial Fibrillation 20%
• Adenocarcinoma 20%
• Carcinoembryonic Antigen 20%
• Systemic Therapy 20%
• Microsatellite Instability 20%
• Colectomy 20%
• Chemotherapy 20%
• Bevacizumab 20%
• Cetuximab 20%
• Surgical Anastomosis 20%
• Liver Injury 20%
• Folinic Acid 20%
• Mutational Analysis 20%
• Abdominal Tenderness 20%
• Tumor 20%
• Pembrolizumab 20%
• Splenic Flexure 20%

Pharmacology, Toxicology and Pharmaceutical Science

• Chemotherapy 100%
• Metastatic Colon Cancer 100%
• Oxaliplatin 100%
• Disease Exacerbation 60%
• Irinotecan 60%
• Colorectal Carcinoma 40%
• Metastatic Colorectal Cancer 40%
• Diseases 20%
• Malignant Neoplasm 20%
• Neoplasm 20%
• Liver Injury 20%
• Fluorouracil 20%
• Atrial Fibrillation 20%
• Adenocarcinoma 20%
• Carcinoembryonic Antigen 20%
• Cetuximab 20%
• Bevacizumab 20%
• Medical History 20%
• Abdominal Tenderness 20%
• Folinic Acid 20%
• Pembrolizumab 20%